Dicot Pharma Dicot Pharma
  • The Pharmaceutical Project
    • The drug candidate LIB-01
    • Sexual dysfunctions
    • The Market
    • Patent
    • Publications
    • Advisory expert group
  • About Dicot Pharma
    • Business idea, strategy & vision
    • Management
    • Board
    • Background
    • Contact
  • Media
    • Articles
    • Films
    • Podcasts
    • DICOTnews
  • Press
    • Press Releases
    • Press Images
  • Investor Relations
    • The share
    • Corporate governance
    • Reports and issues
    • Financial calendar and events
    • Analysis
    • Subscribe
  • Subscribe
  • The Pharmaceutical Project
    • The drug candidate LIB-01
    • Sexual dysfunctions
    • The Market
    • Patent
    • Publications
    • Advisory expert group
  • About Dicot Pharma
    • Business idea, strategy & vision
    • Management
    • Board
    • Background
    • Contact
  • Media
    • Articles
    • Films
    • Podcasts
    • DICOTnews
  • Press
    • Press Releases
    • Press Images
  • Investor Relations
    • The share
    • Corporate governance
    • Reports and issues
    • Financial calendar and events
    • Analysis
    • Subscribe
  • Subscribe
  • På svenska
På svenska
  • Home/
  • Press/
  • Press Releases
< Back

Dicot Pharma is developing a modern potency drug that will treat erectile dysfunction and premature ejaculation better than existing drugs.

Follow us on linkedIn  

Dicot Pharma AB
S:t Olofsgatan 11A
SE-753 21 Uppsala
SWEDEN

+46 72 502 10 10
[email protected]

© Copyright Dicot Pharma AB.
All rights reserved.

Change settings for cookies

Integrity policy and GDPR

Annual report 2025

Our website uses cookies to improve your experience and for targeted marketing.
You can configure what you want to accept and read more about the cookies we use here.

Accept all